BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Supriya Lifescience Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543434
ISIN Demat
INE07RO01027
Book Value (Rs)
134.4133852
NSE Symbol
SUPRIYA
Divident Yield %
0.14
Market Cap
(Rs In Cr.)
5,906
P/E (TTM)
31.82
EPS (TTM)
23.06
Face Value
(Rs)
2
Back
Supriya Lifescience standalone net profit rises 9.27% in the September 2025 quarter
13-Nov-25   Hrs IST

Net profit of Supriya Lifescience rose 9.27% to Rs 50.43 crore in the quarter ended September 2025 as against Rs 46.15 crore during the previous quarter ended September 2024. Sales rose 20.31% to Rs 199.83 crore in the quarter ended September 2025 as against Rs 166.10 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales199.83166.10 20
OPM %36.3638.96 -
PBDT74.9666.81 12
PBT68.3262.07 10
NP50.4346.15 9

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)